相关实验视频
Updated: Jun 26, 2025
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.4K
治疗IL-6受体抗体改善了实验性自身免疫性脑筋硬化症小鼠模型中的肌肉虚弱
Shota Miyake1, Kenichi Serizawa1, Shinichi Onishi1
1Product Research Department, Chugai Pharmaceutical Co., Ltd., Yokohama, Japan.
Frontiers in neurology
|May 16, 2024
概括
干白素-6受体 (IL-6R) 抗体治疗有效地改善了肌肉软弱,并减少了小鼠模型中肌痛性肌痛 (MG) 的自身抗体. 这表明IL-6R阻断是MG的有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 骨髓灰质炎 (MG) 是一种慢性自身免疫性神经肌肉结合障碍.
- 对乙胆受体 (AChR) 的病理性自身抗体导致MG的肌肉衰弱和疲劳.
- 介质素-6 (IL-6) 参与MG病变的发生表明IL-6受体 (IL-6R) 阻断是潜在的治疗方法.
研究的目的:
- 在实验性自身免疫MG (EAMG) 鼠标模型中研究IL-6R抗体治疗的治疗效果.
- 评估IL-6R阻断对EAMG中的临床症状和免疫标记物的影响.
主要方法:
- 建立了一个实验性自身免疫MG (EAMG) 鼠标模型.
- 小鼠接受了IL-6R抗体的治疗.
- 分析了肌肉功能,神经肌肉结点的IgG沉积,ACHR自身抗体水平和免疫细胞群 (Tfh,Th17,血细胞).
主要成果:
- 在EAMG小鼠中,IL-6R抗体治疗显著改善了肌肉软弱.
- 治疗减少了神经肌肉结点的IgG沉积和血清AChR自身抗体水平.
- 在接受治疗的小鼠中观察到毛囊辅助T细胞,Th17细胞和血细胞的数量减少.
结论:
- IL-6R阻断在改善EAMG方面表现出有效性.
- 向IL-6R提供了一个潜在的新型治疗策略,用于肌痛性骨髓灰质炎.
- 这项研究强调了IL-6信号在MG病变发生和免疫细胞调节中的作用.
更多相关视频
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.7K
10:35Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
8.3K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
791
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
791
01:28Disorders of the Skeletal Muscle
932
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
932